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Treatment of Coronary In-Stent Restenosis
With Bioabsorbable Vascular Scaffolds
Fernando Alfonso, MD, Julio Nuccio, MD, Cecilia Cuevas, MD, Alberto Cárdenas, MD,
Nieves Gonzalo, MD, Pilar Jimenez-Quevedo, MD
Madrid, Spain77-year-old woman was admitted for angina 13 years after receiving a bare-metal stent inAthe left anterior descending coronary artery. Angiography showed in-stent restenosis(ISR). Optical coherence tomography (OCT) revealed a well-expanded stent with focal
ISR (arrow in longitudinal display, A) and heterogeneous tissue, including lipid pools (D) and and
calciﬁed segments (#), suggesting neoatherosclerosis (B to D) (wire-artifact [*]). Most underlying
struts were not visible. A bioabsorbable vascular scaffold (BVS) was deployed and subsequently
post-dilated at high pressures to remove a residual waist. Final OCT revealed a minimal lumen
area of 8 mm2. The classic “black box” BVS appearance (without shadowing) was identiﬁed, well
apposed on residual intrastent tissue, overlying the bright artifacts (sharp shadows) of the un-
derlying metallic struts (E to G). The therapy of choice for neoatherosclerosis remains unknown.
BVS may emerge as an attractive therapeutic strategy for selected patients with ISR. In this setting,
BVS avoids the need for an additional metal layer on the vessel wall. OCT provides unique in-
sights on this novel therapeutic strategy.
